<DOC>
	<DOCNO>NCT00814944</DOCNO>
	<brief_summary>The purpose study determine safety efficacy ocular sirolimus ( rapamycin ) formulation compare Placebo sign symptom dry eye CAE Model .</brief_summary>
	<brief_title>A Dose-Ranging Clinical Study Assess Safety Efficacy Subconjunctival Injection Sirolimus Patients With Dry Eye Controlled Adverse Environmental ( CAE ) Model</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Inclusion Criteria include , limited : Have report history dry eye eye ; Have history use desire use eye drop dry eye symptom within past 6 month . Exclusion Criteria include , limited : Have contraindication use study medication ; Have know allergy sensitivity use study medication diagnostic dye ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>dry eye</keyword>
	<keyword>sirolimus</keyword>
	<keyword>rapamycin</keyword>
</DOC>